-
1
-
-
77953124970
-
Plasma copeptin and the risk of diabetes mellitus
-
Enhörning S, Wang TJ, Nilsson PM, et al. Plasma copeptin and the risk of diabetes mellitus. Circulation 2010;121:2102-2108
-
(2010)
Circulation
, vol.121
, pp. 2102-2108
-
-
Enhörning, S.1
Wang, T.J.2
Nilsson, P.M.3
-
2
-
-
0018755966
-
Plasma vasopressin in uncontrolled diabetes mellitus
-
Zerbe RL, Vinicor F, Robertson GL. Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 1979;28:503-508 (Pubitemid 9190908)
-
(1979)
Diabetes
, vol.28
, Issue.5
, pp. 503-508
-
-
Zerbe, R.L.1
Vinicor, F.2
Robertson, G.L.3
-
3
-
-
0035101494
-
Vasopressin and diabetes mellitus
-
DOI 10.1159/000045879
-
Bankir L, Bardoux P, Ahloulay M. Vasopressin and diabetes mellitus. Nephron 2001;87: 8-18 (Pubitemid 32171114)
-
(2001)
Nephron
, vol.87
, Issue.1
, pp. 8-18
-
-
Bankir, L.1
Bardoux, P.2
Ahloulay, M.3
-
4
-
-
0018219567
-
Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspension
-
Whitton PD, Rodrigues LM, Hems DA. Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions. Biochem J 1978;176: 893-898 (Pubitemid 9090472)
-
(1978)
Biochemical Journal
, vol.176
, Issue.3
, pp. 893-898
-
-
Whitton, P.D.1
Rodrigues, L.M.2
Hems, D.A.3
-
5
-
-
0021908941
-
The effect of vasopressin infusion on glucose metabolism in man
-
Spruce BA, McCulloch AJ, Burd J, et al. The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf) 1985;22:463-468 (Pubitemid 15149171)
-
(1985)
Clinical Endocrinology
, vol.22
, Issue.4
, pp. 463-468
-
-
Spruce, B.A.1
McCulloch, A.J.2
Burd, J.3
-
6
-
-
0025217635
-
2 selective ligands
-
Phillips PA, Abrahams JM, Kelly JM, Mooser V, Trinder D, Johnston CI. Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands. Endocrinology 1990;126:1478-1484 (Pubitemid 20095752)
-
(1990)
Endocrinology
, vol.126
, Issue.3
, pp. 1478-1484
-
-
Phillips, P.A.1
Abrahams, J.M.2
Kelly, J.M.3
Mooser, V.4
Trinder, D.5
Johnston, C.I.6
-
7
-
-
0028179172
-
3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes
-
3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes. Biochem Biophys Res Commun 1994;199:353-360
-
(1994)
Biochem Biophys Res Commun
, vol.199
, pp. 353-360
-
-
Serradeil-Le Gal, C.1
Raufaste, D.2
Marty, E.3
Garcia, C.4
Maffrand, J.P.5
Le Fur, G.6
-
8
-
-
0041965818
-
1b receptors: Characterization in In-R1-G9 cells and localization in human pancreas
-
Folny V, Raufaste D, Lukovic L, et al. Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas. Am J Physiol Endocrinol Metab 2003;285: E566-E576 (Pubitemid 37010835)
-
(2003)
American Journal of Physiology - Endocrinology and Metabolism
, vol.285
, Issue.3
-
-
Folny, V.1
Raufaste, D.2
Lukovic, L.3
Pouzet, B.4
Rochard, P.5
Pascal, M.6
Serradeil-Le, G.C.7
-
9
-
-
1342265782
-
Vasopressin Stimulates Insulin Release from Islet Cells through V1b Receptors: A Combined Pharmacological/Knockout Approach
-
DOI 10.1124/mol.65.3.623
-
Oshikawa S, Tanoue A, Koshimizu TA, Kitagawa Y, Tsujimoto G. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach. Mol Pharmacol 2004;65:623-629 (Pubitemid 38264029)
-
(2004)
Molecular Pharmacology
, vol.65
, Issue.3
, pp. 623-629
-
-
Oshikawa, S.1
Tanoue, A.2
Koshimizu, T.-A.3
Kitagawa, Y.4
Tsujimoto, G.5
-
10
-
-
72949095441
-
Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort
-
Meijer E, Bakker SJ, Halbesma N, de Jong PE, Struck J, Gansevoort RT. Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney Int 2010;77: 29-36
-
(2010)
Kidney Int
, vol.77
, pp. 29-36
-
-
Meijer, E.1
Bakker, S.J.2
Halbesma, N.3
De Jong, P.E.4
Struck, J.5
Gansevoort, R.T.6
-
11
-
-
56149124681
-
Predicting diabetes: Clinical, biological, and genetic approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR)
-
Balkau B, Lange C, Fezeu L, et al. Predicting diabetes: clinical, biological, and genetic approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2008;31:2056-2061
-
(2008)
Diabetes Care
, vol.31
, pp. 2056-2061
-
-
Balkau, B.1
Lange, C.2
Fezeu, L.3
-
12
-
-
77949277852
-
Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: The role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR)
-
DESIR Study Group.
-
Gautier A, Balkau B, Lange C, Tichet J, Bonnet F; DESIR Study Group. Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetologia 2010;53:247-253
-
(2010)
Diabetologia
, vol.53
, pp. 247-253
-
-
Gautier, A.1
Balkau, B.2
Lange, C.3
Tichet, J.4
Bonnet, F.5
-
13
-
-
0036237653
-
Alcohol intake and fasting insulin in French men and women. The D.E.S.I.R. study
-
Konrat C, Mennen LI, Cace&3grave;s E, et al.; the D.E.S.I.R. Study Group. Alcohol intake and fasting insulin in French men and women. The D.E.S.I.R. Study. Diabetes Metab 2002;28:116-123 (Pubitemid 34437403)
-
(2002)
Diabetes and Metabolism
, vol.28
, Issue.2
, pp. 116-123
-
-
Konrat, C.1
Mennen, L.I.2
Caces, E.3
Lepinay, P.4
Rakotozafy, F.5
Forhan, A.6
Balkau, B.7
|